[Retracted] Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer

Table 2

The serum levels of CEA, CA153, and CA125 between the conventional and combined groups before and after treatment.

Time	Group	CEA (ng/ml)	CA153 (U/ml)	CA125 (U/ml)
Before	Conventional (n = 75)	54.56 ± 5.52	55.14 ± 5.05	154.33 ± 16.85
	Combined (n = 75)	54.29 ± 6.43^b	56.37 ± 5.48^b	155.94 ± 15.57^b
t		0.171	0.482	0.726
		0.271	0.119	0.094
After	Conventional (n = 75)	33.46 ± 4.03^a	38.12 ± 3.06^a	67.91 ± 5.87^a
	Combined (n = 75)	20.14 ± 3.04^ab	22.19 ± 1.10^ab	24.65 ± 3.99^ab
t		7.184	8.016	7.253
		0.001	0.001	0.001

^a for comparison in the same group before and after treatment; ^b compared with the conventional group.